The 27th Annual Meeting of KSOT/KEMS
* Period : November 3~4, 2011
* Venue : Hyatt Regency Hotel, Jeju, Korea
* Theme : A Systematic Approach for Toxicology: From the Basics to Disease
* Host & Organizing Committees
|
: Byung Mu Lee, PhD (Sungkyunkwan University) |
|
: Myung-Haing Cho (Seoul National University) |
Nov. 3 (Thu.)
|
11:50~13:00 |
Council Meeting |
|
11:50~13:10 |
Registration |
|
13:10~13:30 |
Opening Ceremony |
|
Plenary Lecture I |
|
|
13:30~14:00 |
Development and prospects of molecular biology in Korea |
|
Symposium 1: Safety Management of Hazardous Chemicals in Consumer Products |
|
|
14:00~14:30 |
Current status and policy direction for safety management of hazardous chemicals in consumer products |
|
14:30~15:00 |
Risk assessment of volatile organic compounds (VOCs) in consumer products |
|
15:00~15:30 |
Management and exposure assessment of phthalates in childcare facilities |
|
15:30~16:00 |
Safety control of consumer products for preventing risks |
|
16:00~16:30 Coffee Break / Poster Session |
|
|
Symposium 2: Molecular Mechanisms Underlying Colon Carcinogenesis |
|
|
16:30~17:20 |
Role of pregnane X receptor (PXR) and hypoxia-inducible factor (HIF) in inflammatory bowel and colon carcinogenesis |
|
17:20~18:00 |
Role of epigenetic modifications in multistage colon carcinogenesis |
|
18:00~18:30 |
KSOT/KEMS General Assembly |
|
18:30~ |
Reception & Award |
Nov. 4 (Fri.)
|
Symposium 3: Lipid and Inflammation |
|
|
09:00~09:30 |
Bioactive lipids and inflammation: Implications in lung injury |
|
09:30~09:55 |
Role of sphingosine 1-phosphate and S1P2 receptor in inflammation and atherosclerosis |
|
09:55~10:20 |
Role of prostaglandin E2 receptor, EP2, in mouse skin carcinogenesis |
|
10:20~10:40 |
Coffee Break / Poster Session |
|
10:40~11:05 |
A protective role of 15-hydroxyprostaglandin dehydrogenase in inflammation-associated carcinogenesis |
|
11:05~11:30 |
Redox regulation of pro-inflammatory and anti-inflammatory signaling by electrophilic lipid mediators |
|
11:30~12:00 |
The role of heme oxygenase-1 and Nrf2 in response to ochratoxin-induced kidney injury |
|
12:00~13:00 |
Lunch / Poster Session |
|
Plenary Lecture II |
|
|
13:00~13:30 |
The current status and the strategy of GLP development in Korea |
|
Symposium 4 : Recent Toxicity Study using Advanced Technology |
|
|
13:30~13:55 |
Transcriptomic approaches to assess kidney toxicity |
|
13:55~14:20 |
Organ-specific biomarker discovery for toxicity using meta-analysis |
|
14:20~14:45 |
Toxicity analysis in kidney using a virtual cell technology |
|
14:45~15:00 |
Coffee Break |
|
Symposium 5 : Recent Issues in the Safety Evaluation |
|
|
15:00~15:20 |
Problems and improved directions on the final reports from GLP-based toxicity test |
|
15:20~15:40 |
Introduction of current state and methods on non-clinical safety evaluation in juvenile animals for pediatric drug products |
|
15:40~16:00 |
Assay platforms for biomarkers in drug discovery and development |
|
16:00~16:20 |
Award Presentation & Closing remarks |